Quoin Pharmaceuticals, Ltd.

NASDAQ (USD): Quoin Pharmaceuticals, Ltd. (QNRX)

Last Price

0.411

Today's Change

-0.179 (30.33%)

Day's Change

0.40 - 0.673

Trading Volume

60,089,382

Profile
QNRX

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Michael Myers Ph.D. Dr. Michael Myers Ph.D.

Full Time Employees:  4 4

IPO Date:  2016-08-01 2016-08-01

CIK:  0001671502 0001671502

ISIN:  US74907L3006 US74907L3006

CUSIP:  74907L102 74907L102

Beta:  1.89 1.89

Last Dividend:  0.00 0.00

Dcf Diff:  -1.15 -1.15

Dcf:  2.66 2.66

Description

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Address

42127 Pleasant Forest Court,
Ashburn, VA 20148-7349, US

703 980 4182

http://quoinpharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment